TrialAmerican journal of respiratory and critical care medicine2024

High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.

Kamunkhwala Gausi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.